This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.




1dtt

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1dtt" size="450" color="white" frame="true" align="right" spinBox="true" caption="1dtt, resolution 3.0&Aring;" /> '''CRYSTAL STRUCTURE OF...)
Line 1: Line 1:
-
[[Image:1dtt.gif|left|200px]]<br />
+
[[Image:1dtt.gif|left|200px]]<br /><applet load="1dtt" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1dtt" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1dtt, resolution 3.0&Aring;" />
caption="1dtt, resolution 3.0&Aring;" />
'''CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 (PETT130A94)'''<br />
'''CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 (PETT130A94)'''<br />
==Overview==
==Overview==
-
Most non-nucleoside reverse transcriptase (RT) inhibitors are specific for, HIV-1 RT and demonstrate minimal inhibition of HIV-2 RT. However, we, report that members of the phenylethylthiazolylthiourea (PETT) series of, non-nucleoside reverse transcriptase inhibitors showing high potency, against HIV-1 RT have varying abilities to inhibit HIV-2 RT. Thus, PETT-1, inhibits HIV-1 RT with an IC(50) of 6 nM but shows only weak inhibition of, HIV-2 RT, whereas PETT-2 retains similar potency against HIV-1 RT (IC(50), of 5 nM) and also inhibits HIV-2 RT (IC(50) of 2.2 microM). X-ray, crystallographic structure determinations of PETT-1 and PETT-2 in, complexes with HIV-1 RT reveal the compounds bind in an overall similar, conformation albeit with some differences in their interactions with the, protein. To investigate whether PETT-2 could be acting at a different site, on HIV-2 RT (e.g. the dNTP or template primer binding site), we compared, modes of inhibition for PETT-2 against HIV-1 and HIV-2 RT. PETT-2 was a, noncompetitive inhibitor with respect to the dGTP substrate for both HIV-1, and HIV-2 RTs. PETT-2 was also a noncompetitive inhibitor with respect to, a poly(rC).(dG) template primer for HIV-2 RT. These results are consistent, with PETT-2 binding in corresponding pockets in both HIV-1 and HIV-2 RT, with amino acid sequence differences in HIV-2 RT affecting the binding of, PETT-2 compared with PETT-1.
+
Most non-nucleoside reverse transcriptase (RT) inhibitors are specific for HIV-1 RT and demonstrate minimal inhibition of HIV-2 RT. However, we report that members of the phenylethylthiazolylthiourea (PETT) series of non-nucleoside reverse transcriptase inhibitors showing high potency against HIV-1 RT have varying abilities to inhibit HIV-2 RT. Thus, PETT-1 inhibits HIV-1 RT with an IC(50) of 6 nM but shows only weak inhibition of HIV-2 RT, whereas PETT-2 retains similar potency against HIV-1 RT (IC(50) of 5 nM) and also inhibits HIV-2 RT (IC(50) of 2.2 microM). X-ray crystallographic structure determinations of PETT-1 and PETT-2 in complexes with HIV-1 RT reveal the compounds bind in an overall similar conformation albeit with some differences in their interactions with the protein. To investigate whether PETT-2 could be acting at a different site on HIV-2 RT (e.g. the dNTP or template primer binding site), we compared modes of inhibition for PETT-2 against HIV-1 and HIV-2 RT. PETT-2 was a noncompetitive inhibitor with respect to the dGTP substrate for both HIV-1 and HIV-2 RTs. PETT-2 was also a noncompetitive inhibitor with respect to a poly(rC).(dG) template primer for HIV-2 RT. These results are consistent with PETT-2 binding in corresponding pockets in both HIV-1 and HIV-2 RT with amino acid sequence differences in HIV-2 RT affecting the binding of PETT-2 compared with PETT-1.
==About this Structure==
==About this Structure==
-
1DTT is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1] with FTC as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1DTT OCA].
+
1DTT is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1] with <scene name='pdbligand=FTC:'>FTC</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DTT OCA].
==Reference==
==Reference==
Line 15: Line 14:
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Balzarini, J.]]
[[Category: Balzarini, J.]]
-
[[Category: Bird, L.E.]]
+
[[Category: Bird, L E.]]
[[Category: Diprose, J.]]
[[Category: Diprose, J.]]
-
[[Category: Esnouf, R.M.]]
+
[[Category: Esnouf, R M.]]
[[Category: Ikemizu, S.]]
[[Category: Ikemizu, S.]]
[[Category: Milton, J.]]
[[Category: Milton, J.]]
[[Category: Ren, J.]]
[[Category: Ren, J.]]
[[Category: Slater, M.]]
[[Category: Slater, M.]]
-
[[Category: Stammers, D.K.]]
+
[[Category: Stammers, D K.]]
-
[[Category: Stuart, D.I.]]
+
[[Category: Stuart, D I.]]
[[Category: Warren, J.]]
[[Category: Warren, J.]]
[[Category: FTC]]
[[Category: FTC]]
Line 30: Line 29:
[[Category: non-nucleoside inhibitor]]
[[Category: non-nucleoside inhibitor]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Thu Nov 8 13:59:10 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:20:21 2008''

Revision as of 10:20, 21 February 2008


1dtt, resolution 3.0Å

Drag the structure with the mouse to rotate

CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 (PETT130A94)

Overview

Most non-nucleoside reverse transcriptase (RT) inhibitors are specific for HIV-1 RT and demonstrate minimal inhibition of HIV-2 RT. However, we report that members of the phenylethylthiazolylthiourea (PETT) series of non-nucleoside reverse transcriptase inhibitors showing high potency against HIV-1 RT have varying abilities to inhibit HIV-2 RT. Thus, PETT-1 inhibits HIV-1 RT with an IC(50) of 6 nM but shows only weak inhibition of HIV-2 RT, whereas PETT-2 retains similar potency against HIV-1 RT (IC(50) of 5 nM) and also inhibits HIV-2 RT (IC(50) of 2.2 microM). X-ray crystallographic structure determinations of PETT-1 and PETT-2 in complexes with HIV-1 RT reveal the compounds bind in an overall similar conformation albeit with some differences in their interactions with the protein. To investigate whether PETT-2 could be acting at a different site on HIV-2 RT (e.g. the dNTP or template primer binding site), we compared modes of inhibition for PETT-2 against HIV-1 and HIV-2 RT. PETT-2 was a noncompetitive inhibitor with respect to the dGTP substrate for both HIV-1 and HIV-2 RTs. PETT-2 was also a noncompetitive inhibitor with respect to a poly(rC).(dG) template primer for HIV-2 RT. These results are consistent with PETT-2 binding in corresponding pockets in both HIV-1 and HIV-2 RT with amino acid sequence differences in HIV-2 RT affecting the binding of PETT-2 compared with PETT-1.

About this Structure

1DTT is a Protein complex structure of sequences from Human immunodeficiency virus 1 with as ligand. Full crystallographic information is available from OCA.

Reference

Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses., Ren J, Diprose J, Warren J, Esnouf RM, Bird LE, Ikemizu S, Slater M, Milton J, Balzarini J, Stuart DI, Stammers DK, J Biol Chem. 2000 Feb 25;275(8):5633-9. PMID:10681546

Page seeded by OCA on Thu Feb 21 12:20:21 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools